InsiderTrades

Form 4 for CNMD CONMED Corp

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001127602-23-008912 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-03 2023-03-01 CNMD Garner Todd W EVP, CFO M - OptEx $0.00 +1,600 1,601 +160,000% $0
D 2023-03-03 2023-03-01 CNMD Garner Todd W EVP, CFO F - Tax $96.16 -486 1,115 -30% -$46.7K
D 2023-03-03 2023-03-01 CNMD Garner Todd W EVP, CFO M - OptEx $0.00 -1,600 0 -100% $0
D 2023-03-03 2023-03-01 CNMD Garner Todd W EVP, CFO A - Grant $0.00 +32.2K 32.2K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 M A 1,600 $0.00 1,601 D — —
2 Common Common Stock 2023-03-01 F D 486 $96.16 1,115 D — —
3 Derivative Rsus (restricted Stock Units) 2023-03-01 M D 1,600 $0.00 0 D $0.00 · — to 2029-03-01 1,600 Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
4 Derivative Options To Purchase Common Stock 2023-03-01 A A 32,212 $0.00 32,212 D $96.16 · — to 2033-03-01 32,212 Common Stock (F2) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period